Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas

1 Mar 2000

Abstract excerpt

Transforming growth factor beta (TGF-beta) is a powerful inhibitor of cell proliferation and a potent inducer of differentiation. Resistance to TGF-beta action is a characteristic of many malignancies and has been attributed to alterations of TGF-beta receptors as well as disturbance of downstream transduction pathways. To analyse the TGF-beta response in neuroblastoma, the expression of TGF-beta1 and TGF-beta...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Neuroblastoma Research and Treatments
Share to TGF-β signaling in diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10735501
DOI: 10.1054/bjoc.1999.1058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomasPMID 10735501Read ↗

Increased TGFbeta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells.Semantic proximity Read ↗

Type III TGF-Î² receptor promotes FGF2-mediated neuronal differentiation in neuroblastomaSemantic proximity Read ↗

Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma.Semantic proximity Read ↗

Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.Semantic proximity Read ↗

Attenuated type II TGF-beta receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic dissemination.Semantic proximity Read ↗

Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosisSemantic proximity Read ↗

Resistance to TGF-β1 correlates with a reduction of TGF-β type II receptor expression in Burkitt’s lymphoma and Epstein–Barr virus-transformed B lymphoblastoid cell linesSemantic proximity Read ↗

Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinomaSemantic proximity Read ↗

Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis.Semantic proximity Read ↗

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.Semantic proximity Read ↗

Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma.Semantic proximity Read ↗

Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.